The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Gastrinoma (Duodenal and Pancreatic)
Open accessAbstract
Gastrinomas are neuroendocrine tumors (NETs), usually located in the duodenum or pancreas, that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome (ZES). ZES is characterized by gastric acid hypersecretion resulting in severe acid-related peptic disease (peptic ulcer disease, PUD; gastro-esophageal reflux disease, GERD) [1,2,3] and diarrhea. In this section ZES, due to both duodenal and pancreatic gastrinomas, will be covered together because clinically they are similar [2, 3]. Specific points related to gastrinomas associated with the genetic syndrome of multiple endocrine neoplasia type 1 (MEN1) will also be mentioned. Some specific points related to duodenal gastrinomas will also be covered in the duodenal carcinoid section.The incidence of gastrinomas is 0.5–3/million population/year. They are the most common functional and, malignant pancreatic endocrine tumor (PET) syndrome and comprise up to 30% of these tumors [3, 4]. Duodenal tumors, which were originally thought to be uncommon (i.e. <20%), now make up 50–88% of gastrinomas in sporadic ZES patients and 70–100% of gastrinomas in MEN1/ZES patients. In rare cases, gastrinomas occur in other nonpancreatic, nonduodenal abdominal (stomach, liver, bile duct, ovary) (5–15%) and extra-abdominal (heart, small cell lung cancer) locations [5,6,7,8].The WHO classification [10] subdivides gastrinomas, similar to other gastroenteropancreatic neuroendocrine tumors (GEP-NETs), into three general categories: (1) well-differentiated endocrine tumors with benign or uncertain behavior at the time of diagnosis (10–30%); (2) well-differentiated endocrine carcinomas with low-grade malignant behavior (50–80%), and (3) poorly differentiated endocrine carcinomas with high-grade malignant behavior (1–3%). The 50–80% of gastrinomas of the pancreas and duodenum that fall into the category of well-differentiated endocrine carcinomas are usually larger than 1 cm and show local invasion and/or proximal lymph node metastases [6, 11]. Liver metastases occur much more frequently with pancreatic gastrinomas (22–35%) than duodenal gastrinomas (0–10%) [6, 12]. Pancreatic gastrinomas are generally large in size (mean 3.8 cm, 6% <1 cm), whereas duodenal gastrinomas are usually small (mean 0.93 cm, 77% <1 cm). While the pancreatic gastrinomas may occur in any portion of the pancreas, duodenal gastrinomas are predominantly found in the first part of the duodenum including the bulb [7]. At surgery 70–85% of gastrinomas are found in the right upper quadrant (duodenal and pancreatic head area), the so-called ‘gastrinoma triangle’ [4, 5, 13]. MEN1 is an autosomal-dominant syndrome that is present in 20–30% of patients with ZES [14]. In these patients duodenal tumors are usually (70–100%) responsible for the ZES. The duodenal tumors are almost always multiple [15,16,17] and originate from diffuse gastrin cell proliferations [18].Histologically, most gastrinomas are well-differentiated and show a trabecular and pseudoglandular pattern. Their proliferative activity (i.e. the Ki-67 index) varies between 2 and 10%, but is mostly close to 2%. Immunohistochemically, all gastrinomas stain for gastrin.Approximately one fourth of ZES patients have gastrinomas that pursue an aggressive course and aggressive growth occurs in 40% of patients with liver metastases. At diagnosis, 5–10% of duodenal gastrinomas and 20–25% of pancreatic gastrinomas are associated with liver metastases. Liver metastases are the most important prognostic factor, the 10-year survival being 90–100% without liver metastases and 10–20% with. Poor prognostic factors besides liver metastases include: inadequate control of gastric acid hypersecretion; presence of lymph node metastases (p = 0.03); female gender (p < 0.001); absence of MEN1 (p <0.001); short disease history from onset to diagnosis (p <0.001); markedly increased fasting gastrin levels (p < 0.001); presence of a large primary tumor (>3 cm) (p < 0.001); a pancreatic primary gastrinoma (p < 0.001); development of ectopic Cushing’s syndrome or bone metastases (p < 0.001); the presence of various flow cytometric features, molecular features (high HER2/neu gene expression (p = 0.03), high 1q LOH, increased EGF of IGF1 receptor expression), or histological features including angioinvasion, perineural invasion, >2 mitoses per 20 HPF, Ki-67 index >2 [5, 6,19,20,21,22,23,24].At the onset of symptoms, the mean age of patients with sporadic gastrinomas is 48–55 years; 54–56% are males, and the mean delay in diagnosis from the onset of symptoms is 5.2 years. All of the symptoms except those late in the disease course are due to gastric acid hypersecretion. The majority of ZES patients present with a single duodenal ulcer or GERD symptoms and ulcer complications. Multiple ulcers or ulcers in unusual locations are a less frequent presenting feature than in the past. Abdominal pain primarily due to PUD or GERD occurs in 75–98% of the cases, diarrhea in 30–73%
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surgery to Cure the Zollinger–Ellison Syndrome
Norton, J. A., Fraker, D. L., Alexander, H. R., Venzon, D. J., Doppman, J. L., Serrano, J., Goebel, S. U., Peghini, P. L., Roy, P. K., Gibril, F., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410902 · Cited by 504
Self-citationFaiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
Weber, H. C., Venzon, D. J., Lin, J.-T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., Norton, J. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90124-8 · Cited by 467
Self-citationGibril, F., Reynolds, J. C., Doppman, J. L., Chen, C. C., Venzon, D. J., Termanini, B., Weber, H. C., Stewart, C. A., & Jensen, R. T. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00005 · Cited by 440
Self-citationAnderson, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01272-7 · Cited by 399
Zollinger-Ellison Syndrome: Clinical Presentation in 261 Patients
Roy, P. K., Venzon, D. J., Shojamanesh, H., Abou-Saif, A., Peghini, P., Doppman, J. L., Gibril, F., & Jensen, R. T. (2000) · Medicine · doi:10.1097/00005792-200011000-00004 · Cited by 351
Self-citationYu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., & Jensen, R. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.615 · Cited by 341
Self-citationGibril, F., Schumann, M., Pace, A., & Jensen, R. T. (2004) · Medicine · doi:10.1097/01.md.0000112297.72510.32 · Cited by 313
Self-citationProspective Study of Thymic Carcinoids in Patients with Multiple Endocrine Neoplasia Type 1
Gibril, F., Chen, Y.-J., Schrump, D. S., Vortmeyer, A., Zhuang, Z., Lubensky, I. A., Reynolds, J. C., Louie, A., Entsuah, L. K., Huang, K., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021314 · Cited by 240
Self-citationSurgery Increases Survival in Patients With Gastrinoma
Norton, J. A., Fraker, D. L., Alexander, H. R., Gibril, F., Liewehr, D. J., Venzon, D. J., & Jensen, R. T. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000234802.44320.a5 · Cited by 238
Self-citationNorton, J. A., & Jensen, R. T. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000143252.02142.3e · Cited by 237
Self-citationHepatic surgery for metastases from neuroendocrine tumors
Sarmiento, J. M., & Que, F. G. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00076-5 · Cited by 227
Curative Resection in Zollinger-Ellison Syndrome Results of a 10-Year Prospective Study
NORTON, J. A., DOPPMAN, J. L., & JENSEN, R. T. (1992) · Annals of Surgery · doi:10.1097/00000658-199201000-00012 · Cited by 218
Self-citationShojamanesh, H., Gibril, F., Louie, A., Ojeaburu, J. V., Bashir, S., Abou‐Saif, A., & Jensen, R. T. (2002) · Cancer · doi:10.1002/cncr.10195 · Cited by 215
Self-citationTermanini, B., Gibril, F., Reynolds, J., Doppman, J., Chen, C., Stewart, C., Sutliff, V., & Jensen, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024287 · Cited by 206
Self-citationManagement of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1
Jensen (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00281.x · Cited by 200
Norton, J. A., Alexander, H. R., Fraker, D. L., Venzon, D. J., Gibril, F., & Jensen, R. T. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00009 · Cited by 199
Self-citationDonow, C., Pipeleers-Marichal, M., Schröder, S., Stamm, B., Heitz, P. U., & Klöppel, G. (1991) · Cancer · doi:10.1002/1097-0142(19910915)68:6<1329::aid-cncr2820680624>3.0.co;2-7 · Cited by 181
Self-citationAlexander, H. R., Fraker, D. L., Norton, J. A., Bartlett, D. L., Tio, L., Benjamin, S. B., Doppman, J. L., Goebel, S. U., Serrano, J., Gibril, F., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199808000-00013 · Cited by 180
Self-citationNorton, J. A., Alexander, H. R., Fraker, D. L., Venzon, D. J., Gibril, F., & Jensen, R. T. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000124290.05524.5e · Cited by 178
Self-citationTermanini, B., Gibril, F., Sutliff, V. E., Yu, F., Venzon, D. J., & Jensen, R. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00087-4 · Cited by 176
Self-citationCadiot, G., Vuagnat, A., Doukhan, I., Murat, A., Bonnaud, G., Delemer, B., Thiéfin, G., Beckers, A., Veyrac, M., Proye, C., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70124-1 · Cited by 169
Cushing's Syndrome in Patients with the Zollinger–Ellison Syndrome
Maton, P. N., Gardner, J. D., & Jensen, R. T. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607033150101 · Cited by 168
Self-citationNorton, J. A., Cornelius, M. J., Doppman, J. L., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1987) · PubMed · Cited by 164
Self-citationManagement of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study.
Sheppard, B. C., Norton, J. A., Doppman, J. L., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1989) · PubMed · Cited by 156
Self-citationAggressive Resection of Metastatic Disease in Selected Patients with Malignant Gastrinoma
Norton, J. A., Sugarbaker, P. H., Doppman, J. L., WESLEY, R. A., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1986) · Annals of Surgery · doi:10.1097/00000658-198604000-00003 · Cited by 155
Self-citationA Prospective Study of Intraoperative Methods to Diagnose and Resect Duodenal Gastrinomas
Sugg, S. L., Norton, J. A., Fraker, D. L., Metz, D. C., Pisegna, J. R., Fishbeyn, V. A., Benya, R. V., Shawker, T. H., Doppman, J. L., & Jensen, R. T. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00004 · Cited by 155
Self-citationTreatment of Neuroendocrine GEP Tumours with Somatostatin Analogues
Arnold, R., Simon, B., & Wied, M. (2000) · Digestion · doi:10.1159/000051861 · Cited by 153
Gibril, F., Doppman, J. L., Reynolds, J. C., Chen, C. C., Sutliff, V. E., Yu, F., Serrano, J., Venzon, D. J., & Jensen, R. T. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1040 · Cited by 142
Self-citationPossible Primary Lymph Node Gastrinoma: Occurrence, Natural History, and Predictive Factors
Norton, J. A., Alexander, H. R., Fraker, D. L., Venzon, D. J., Gibril, F., & Jensen, R. T. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000064375.51939.48 · Cited by 141
Self-citationLehy, T., Cadiot, G., Mignon, M., Ruszniewski, P. B., & Bonfils, S. (1992) · Gut · doi:10.1136/gut.33.9.1275 · Cited by 140
Reflux esophagitis in patients with Zollinger-Ellison syndrome
Miller, L. S., Vinayek, R., Frucht, H., Gardner, J. D., Jensen, R. T., & Maton, P. N. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90823-j · Cited by 139
Self-citationMacfarlane, M., Fraker, D. L., Alexander, H. R., Norton, J. A., Lubensky, I. A., & Jensen, R. T. (1995) · Surgery · doi:10.1016/s0039-6060(05)80102-3 · Cited by 135
Self-citationFishbeyn, V. A., Norton, J. A., Benya, R. V., Pisegna, J. R., Venzon, D. J., Metz, D. C., & Jensen, R. T. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-3-199308010-00004 · Cited by 135
Self-citationLocation, incidence, and malignant potential of duodenal gastrinomas.
Thom, A. K., Norton, J. A., Axiotis, C. A., & Jensen, R. T. (1991) · PubMed · Cited by 134
Self-citationAnlauf, M., Perren, A. A., Meyer, C. L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.058 · Cited by 133
Self-citationGastric Secretion in Zollinger-Ellison Syndrome
Roy, P. K., Venzon, D. J., Feigenbaum, K. M., Koviack, P. D., Bashir, S., Ojeaburu, J. V., Gibril, F., & Jensen, R. T. (2001) · Medicine · doi:10.1097/00005792-200105000-00005 · Cited by 133
Self-citationGastrinomas: comparison of MR imaging with CT, angiography, and US.
Frucht, H., Doppman, J. L., Norton, J. A., Miller, D. L., Dwyer, A. J., Frank, J. A., Vinayek, R., Maton, P. N., & Jensen, R. T. (1989) · Radiology · doi:10.1148/radiology.171.3.2655004 · Cited by 132
Self-citationKlöppel, G., & Anlauf, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.010 · Cited by 129
Self-citationDetection of duodenal gastrinomas by operative endoscopic transillumination
Frucht, H., Norton, J. A., London, J. F., Vinayek, R., Doppman, J. L., Gardner, J. D., Jensen, R. T., & Maton, P. N. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90466-e · Cited by 125
Self-citationRole of Selective Angiography in the Management of Patients With Zollinger-Ellison Syndrome
Maton, P. N., Miller, D. L., Doppman, J. L., Collen, M. J., Norton, J. A., Vinayek, R., Slaff, J. I., Wank, S. A., Gardner, J. D., & Jensen, R. T. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90964-4 · Cited by 124
Self-citationNatural History of Neuroendocrine Enteropancreatic Tumors
Mignon, M. (2000) · Digestion · doi:10.1159/000051856 · Cited by 124
Raufman, J., Collins, S. M., Pandol, S. J., Korman, L. Y., Collen, M. J., Cornelius, M. J., Feld, M. K., McCarthy, D. M., Gardner, J. D., & Jensen, R. T. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80173-5 · Cited by 122
Self-citationMULTIPLE ENDOCRINE NEOPLASIA TYPE 1
Thakker, R. V. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70150-x · Cited by 117
Ruszniewski, P. B., Amouyal, P., Amouyal, G., Grangé, J., Mignon, M., Bouché, O., & Bernades, P. (1995) · Surgery · doi:10.1016/s0039-6060(95)80005-0 · Cited by 113
Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns.
Sutliff, V. E., Doppman, J. L., Gibril, F., Venzon, D. J., Yu, F., Serrano, J., & Jensen, R. T. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2420 · Cited by 108
Self-citationMaton, P. N., Frucht, H., Vinayek, R., Wank, S. A., Gardner, J. D., & Jensen, R. T. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90415-5 · Cited by 108
Self-citationGibril, F., & Jensen, R. T. (2003) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.11.024 · Cited by 108
Self-citationEndocrine Tumors of the Gut and Pancreas Tumor Biology and Classification
Rindi, G., & Klöppel, G. (2004) · Neuroendocrinology · doi:10.1159/000080733 · Cited by 105
Self-citationCurrently used doses of omeprazole in Zollinger-Ellison syndrome are too high
Metz, D. C., Pisegna, J. R., Fishbeyn, V. A., Benya, R. V., Feigenbaum, K. M., Koviack, P. D., & Jensen, R. T. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91170-9 · Cited by 97
Self-citationPisegna, J. R., Norton, J. A., Slimak, G. G., Metz, D. C., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90157-t · Cited by 96
Self-citationLebtahi, R., Cadiot, G., Delahaye, N., Génin, R., Daou, D., Peker, C., Chosidow, D., Faraggi, M., Mignon, M., & Guludec, D. L. (1999) · PubMed · Cited by 93
Control of gastric acid hypersecretion in the management of patients with Zollinger‐Ellison syndrome
Metz, D. C., Pisegna, J. R., Fishbeyn, V. A., Benya, R. V., & Jensen, R. T. (1993) · World Journal of Surgery · doi:10.1007/bf01655106 · Cited by 91
Self-citationGibril, F., & Jensen, R. T. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0067-5 · Cited by 91
Self-citationCorleto, V. D., Annibale, B., Gibril, F., Angeletti, S., Serrano, J., Venzon, D. J., Fave, G. D., & Jensen, R. T. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01085.x · Cited by 91
Self-citationMetz, D. C., Strader, D. B., Orbuch, M., Koviack, P. D., Feigenbaum, K. M., & Jensen, R. T. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00140.x · Cited by 91
Self-citationPeptide receptor radionuclide therapy
Teunissen, J. J. M., Kwekkeboom, D. J., de Jong, M., Esser, J.-P., Valkema, R., & Krenning, E. P. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.04.001 · Cited by 86
Norton, J. A., & Jensen, R. T. (2003) · Surgical Oncology · doi:10.1016/s0960-7404(03)00035-5 · Cited by 66
Self-citationMignon, & Cadiot (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00287.x · Cited by 65
Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome
Gibril, F., & Jensen, R. T. (2005) · Current Gastroenterology Reports · doi:10.1007/s11894-005-0049-2 · Cited by 53
Self-citationMultiple hormone elevations in Zollinger-Ellison syndrome
Chiang, H., O’Dorisio, T. M., Huang, S. C., Maton, P. N., Gardner, J. D., & Jensen, R. T. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90459-e · Cited by 47
Self-citationAdvances in Gastric Antisecretory Therapy in Zollinger-Ellison Syndrome
Metz, D. C., & Jensen, R. T. (2015) · Frontiers of gastrointestinal research · doi:10.1159/000423503 · Cited by 42
Self-citationManagement of metastatic endocrine tumours
Plöckinger, U., & Wiedenmann, B. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.013 · Cited by 34
Cited by
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Self-citationPavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Self-citationGastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Metz, D. C., & Jensen, R. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.047 · Cited by 816
Self-citationJensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Self-citationNANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Self-citation
Metadata
- Authors
- Jensen, R. T., Niederle, B., Mitry, E., Ramage, J. K., Steinmüller, T., Lewington, V., Scarpa, A., Sundin, A., Perren, A., Gross, D., O’Connor, J. M., Pauwels, S., & Klöppel, G.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 84
- Issue
- 3
- Pages
- 173-182
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W1999715445
- Cited by
- 284
- References
- 63
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.